Sponsor

European Lung Cancer Working Party

Clinical research sponsor

Published trials12
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

12 shown
Immunotherapy in Lung Cancer: Treatment After IO Cessation.NCT04465942 · lead sponsor · 2020-06-26
UNKNOWN
Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective RegistryNCT03368820 · lead sponsor · 2017-12-04
UNKNOWN
Has Inflammation a Significant Implication in Lung Cancer Evolution?NCT02484872 · lead sponsor · 2015-05-01
UNKNOWN
Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary NodulesNCT01779388 · lead sponsor · 2013-01-01
COMPLETED
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung CancerNCT00864266 · lead sponsor · 2009-03-01
COMPLETED
A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and EtoposideNCT00759824 · lead sponsor · 2008-09-01
COMPLETED
Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.NCT00759382 · lead sponsor · 2008-07-01
UNKNOWN
Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerNCT00633568 · lead sponsor · 2007-01-01
TERMINATED
Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction ChemotherapyNCT00661011 · lead sponsor · 2007-01-01
TERMINATED
Phase II Study of Valproate and Doxorubicin in Malignant MesotheliomaNCT00634205 · lead sponsor · 2006-07-01
COMPLETED
Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerNCT00622349 · lead sponsor · 2004-02-01
COMPLETED
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung CancerNCT00658580 · lead sponsor · 2000-04-01
COMPLETED

Sponsor roles

lead sponsor12

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.